Tuxiflud Scir 150ml 15mg/5ml

PHARMACOTHERAPEUTIC CATEGORY
Mucolytic.

INDICATIONS
Treatment of secretion disorders in acute and chronic bronchopulmonary affections.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Severe hepatic and / or renal disorders.

DOSAGE
SOLUTION TO NEBULIZE. Adults and children older than 5 years: 2-3 ml of solution 1-2 times a day. Children younger 'less than 5 years: 2 ml of solution 1-2 times a day. Since coughing may occur in deep breathing of aerosols, one should try to breathe normally during inhalation. It is recommended to warm the solution to body temperature before inhalation. In patients with bronchial asthma it is recommended to administer the usual bronchospasmolytic before inhalation. The solution to be nebulized can be administered using normal aerosol therapy devices. It can also be diluted in distilled water in the ratio 1: 1. SYRUP. Adults: 10 ml (30 mg) 3 times a day. Children up to 2 years: 2.5 ml (7.5 mg) 2 times a day. Children 2 to 5 years: 2.5ml (7.5mg) 3 times a day. Children over 5 years: 5 ml (15 mg) 3 times a day. It is recommended to take the syrup after meals. Do not use ambroxol for prolonged treatments.

INTERACTIONS
It generally does not interfere with other medications.

SIDE EFFECTS
Rarely: tiredness, dry mouth, rhinorrhea, dysuria, headache, gastrointestinal disturbances (heartburn, dyspepsia, constipation, nausea and vomiting), contact dermatitis or other allergic reactions (especially skin rashes).